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Abstract
Background: A majority of stroke survivors present with cognitive impairments. Attention disturbance, which leads
to impaired concentration and overall reduced cognitive functions, is strongly associated with stroke. The clinical
efficacy of acupuncture with Baihui (GV20) and Shenting (GV24) as well as computer-assisted cognitive training
in stroke and post-stroke cognitive impairment have both been demonstrated in previous studies. To date, no
systematic comparison of these exists and the potential beneficial effects of a combined application are yet to be
examined. The main objective of this pilot study is to evaluate the effects of computer-assisted cognitive training
compared to acupuncture on the outcomes of attention assessments. The second objective is to test the effects of
a combined cognitive intervention that incorporates computer-assisted cognitive training and acupuncture (ACoTrain).
Methods/Design: An international multicentre, single-blinded, randomised controlled pilot trial will be
conducted. In a 1:1:1 ratio, 60 inpatients with post-stroke cognitive dysfunction will be randomly allocated
into either the acupuncture group, the computer-assisted cognitive training group, or the ACoTrain group
in addition to their individual rehabilitation programme. The intervention period of this pilot trial will last
4 weeks (30 minutes per day, 5 days per week, Monday to Friday). The primary outcome is the test battery
for attentional performance. The secondary outcomes include the Trail Making Test, Test des Deux Barrages,
National Institute of Health Stroke Scale, and Modified Barthel Index for assessment of daily life competence,
and the EuroQol Questionnaire for health-related quality of life.
Discussion: This trial mainly focuses on evaluating the effects of computer-assisted cognitive training compared
to acupuncture on the outcomes of attention assessments. The results of this pilot trial are expected to provide new
insights on how Eastern and Western medicine can complement one another and improve the treatment
of cognitive impairments in early stroke rehabilitation. Including patients with different cultural backgrounds
allows a more generalisable interpretation of the results but also poses risks of performance bias. Using standardised
and well-described assessments, validated for each region, is pivotal to allow pooling of the data.
Trial registration: Clinical Trails.gov ID: NCT02324959 (8 December 2014)
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Background
Cognitive impairment is a condition characterised by
mental deficits. Cognitive deficits occur in more than
half of stroke survivors and are deemed to be more im-
portant determinants of health- and quality of life-
related outcomes than physical disability [1, 2]. The
most common type of cognitive deficit is impaired atten-
tion, with a point prevalence between 46 % and 92 %
reported in acute stroke survivors [3]. These deficits
along with difficulties to concentrate and continued
decline in cognitive functions severely affect quality of
life [4–7].
Attention is closely related to and involved in most
cognitive functions, such as most processes of percep-
tion, memory [8], planning and acting [8], speech per-
ception [9], spatial orienting [10], and social problem-
solving [11]. Accordingly, attention can be considered a
basic competence necessary for most practical and intel-
lectual performances [12]. Consequently, it cannot be
isolated, whether conceptually or functionally, from
other cognitive functions. It has further been shown that
these deficits impair certain motor abilities and inhibit
motor learning [13]. Impairments of attention are a
major problem for people with stroke and affect rehabili-
tation outcome [14]. A systematic review on cognitive
training for post-stroke attention deficits, which in-
cluded six randomised controlled trials (RCTs) with 223
participants [14], suggested that there may be a short-
term effect on attention abilities. However, due to the
methodological limitations of the reported studies, there
was insufficient evidence to support or refute the persist-
ing effects of cognitive rehabilitation on attention or on
functional outcomes.
Acupuncture is one of the main modalities of treat-
ment in Traditional Chinese Medicine (TCM) and has a
practical history of more than 2000 years in China [15].
A recent meta-analysis [16] was conducted to evaluate
the efficacy of acupuncture on cognitive impairment
(function) after stroke. Twenty-one trials with a total of
1421 patients were included. The cumulative findings
suggest that acupuncture has positive effects on cogni-
tive function after stroke. According to TCM theory of
acupuncture, the Du meridian plays an important role in
treating attention problems [17]. Baihui (GV20) and
Shenting (GV24) are two main acupoints from the Du
meridian which are believed to activate the spirit. Previ-
ous studies with experimentally induced cerebral ische-
mia injuries in rodents [18, 19] showed improved
learning and memory abilities after 4 weeks (five times
per week, 30 minutes per time) of Baihui (GV20) and
Shenting (GV24) acupuncture treatment. However,
the existing literature of the effects of acupuncture on
cognitive impairment after stroke describes general
cognitive functions and do not provide sufficient
evidence as to how acupuncture could improve atten-
tion deficits after stroke.
The aims of our study are: (1) to observe the effect of
acupuncture combined with RehaCom training on cog-
nitive dysfunction (in particular attention disturbances)
after stroke, and (2) to test efficacy compared to conven-
tional treatment combined with acupuncture or conven-
tional treatment combined with RehaCom training.
Methods
Study design and setting
The study is designed as an international multicentre
study with randomised, controlled group comparators
and blinded assessors. The study will be an explorative
pilot study with three parallel treatment groups: computer-
assisted cognitive training (CaCT), acupuncture (AP), and
intervention that incorporates CaCT and AP (ACoTrain,
ACT). Three neurological rehabilitation clinics from three
different countries will be involved in recruitment, treat-
ments and assessments. Each clinic will aim to recruit 20
inpatients currently recovering from their clinically first-
ever stroke. Attention performance will be assessed as the
primary study outcome in all groups before and after a 4-
week intervention. The multicentric body of trial centres
consists of specialised neurological rehabilitation centres
from China (Fujian University of Traditional Chinese
Medicine, A), Switzerland (Reha Rheinfelden, B), and
Germany (m&i Fachklinik Herzogenaurach, C). Fig. 1 illus-
trates the flow chart of patient allocation and study design.
Sample size
The international setting is thought to increase the gen-
eralisability of the study results, as the study sample will
include patients with different cultural background.
However, it is also expected that high heterogeneity re-
garding affected cortical areas and functional ability
within the study groups of stroke patients will occur.
The number of participants will therefore not suffice to
conduct a full-scale study but are thought to provide a
basis for estimation of the effects and planning of a
larger follow-up study, if proven feasible.
The aim is to recruit 20 patients per clinic (Ntotal = 60).
The results will be used to compute sample size and
conduct a power calculation to plan the full-scale
follow-up study.
Participant and recruitment
The participants will be recruited from three inpatient
stroke rehabilitation units from (1) Fujian University of
Traditional Chinese Medicine Subsidiary Rehabilitation
Hospital; (2) m&i-Fachklinik Herzogenaurach; and (3)
Reha Rheinfelden. Patients will be identified and re-
cruited via the clinic’s database according to diagnosis
and medical referral. Respective medical personnel will
Huang et al. Trials  (2015) 16:546 Page 2 of 10
be asked to invite patients from the population under inves-
tigation. Patients who express a general interest in taking
part in the study will meet with one of the study personnel
to receive all necessary information in oral and written
form. After a 24-hour consideration period, the patient will
be reapproached by the investigator to resolve any uncer-
tainties and to be invited to sign informed consent after an
assessment of eligibility criteria. After baseline assessment,
patients who meet the inclusion criteria will be randomly
allocated to one of the three study groups. A CONSORT
diagram of participant recruitment is shown in Table 1.
Inclusion criteria
In order to properly understand and apply the training
methods and the content of the study, the patients are
required to have some level of cognition. To assess the
minimum level required, the Montreal Cognitive Assess-
ment (MoCA) [20] will be applied at baseline (BL). Pa-
tients eligible for the trial must comply with all of the
following criteria prior to randomisation: (1) clinically
first-ever stroke, diagnosis confirmed by CT or MRI; (2)
aged between 18 and 80 years old; (3) clinically con-
firmed attention deficits (>1SD below mean of age-
matched norm in at least one subtest of the Test for At-
tentional Performance, TAP); (4) inclusion within
6 months after stroke onset; (5) conscious, stable phys-
ical condition; and (6) given oral and written consent
confirmed by the signature of the patient.
Exclusion criteria
Patients who are positive to one or more of the follow-
ing criteria will have to be excluded: (1) self-reported se-
vere visual problems (inability to recognise illustrations
on MoCA); (2) hearing problems (TAP discrimination of
tones >1SD of aged-matched norm); (3) notable defi-
ciencies in MoCA submodalities on visuospatial and at-
tention assessments, neglect or hemianopia <2 points on
visuospatial assessments, failed attention test (read list of
letters and tap on every A), inability to concentrate
throughout the MoCA assessment, inability to execute a
standardised three-step instruction: “Please take this
piece of paper, fold it twice to fit it in this standardized
envelope and hand it back to me.”; (5) speech compre-
hension deficits: <9 points on the short aphasia test
(KAP); (6) seizures; (7) pre-existing psychological disor-
ders prior to stroke; (8) severe medical condition (e.g.
Fig. 1 Flow diagram of study design including the process of recruitment, allocation and intervention, and assessment
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critical diabetes with hyper- or hypoglycemia); (9) preg-
nancy (in doubt, a pregnancy test will be required); (10)
self-reported, family-reported or neuropsychological as-
sessment proves cognitive decline in history before the
onset of stroke.
Randomization and blinding
For the randomisation, restricted randomisation with
random block sizes between 3 and 9 (exact size to be de-
termined by an external institution) will be used. This
will reduce opportunities for bias and confounding and
increases the probability to meet the assumptions of
statistical analysis (treatment groups are random samples
of population) [21]. Each centre will receive a computer-
generated randomisation list (MATLAB 2007b, Math-
works Inc., Natick, MA, USA) from a third-party partner
institution, which is elsewise not involved in the
study. Sequentially numbered opaque and sealed en-
velopes will be distributed to each trial centre by a
third-party employer, who is not part of the investi-
gating team. The treating therapist will inform the
participants after baseline assessment immediately be-
fore the first treatment. The assessor remains unin-
formed about group allocation. Patients will be
informed and reminded not to mention the study
treatment in front of the assessors.
Ethical issues
This study will be conducted in compliance with study
protocol and the current version of the Declaration of
Helsinki. All participants will be fully informed about
the trial, and will sign the written informed consent
form prior to participation. The trial has been ap-
proved by the ethics committee of the Rehabilitation
Hospital affiliated to Fujian University of Traditional
Chinese Medicine (Approval No. 2013KY-004-02); the
local committee responsible for Germany – the Med-
ical Faculty of the Friedrich-Alexander University in
Erlangen-Nürnberg (Approval No. 119_14Mz); and the
local ethics committee responsible for Northwestern and
Central Switzerland (Ethikkommission Nordwest und
Zentralschweiz EKNZ) (Approval No. EKNZ 2014–106).
Interventions
All study interventions are described in Table 2 using
the Template for Intervention Description and Replica-
tion checklist and guide, known as TIDieR. Patients will
be evenly allocated to CaCT, AP, or ACT. All groups will
additionally receive conventional neurorehabilitative
treatment as prescribed by each clinic. The experimental
intervention of this trial will be added to the existing
therapy plan as a daily treatment of 30 minutes for
4 weeks (Monday to Friday). Every treatment will be
documented on the therapy documentation sheet (stan-
dardised for each trial centre).
Conventional therapy
All participants will receive basic treatment according to
the rehabilitation concept applied in the individual
clinics and/or as demanded by cost bearers. Multidiscip-
linary treatment will include physiotherapy, occupational
therapy, medical exercise therapy, hydrotherapy, etc.
Table 1 Trial processes chart
Study periods Admission 1st contact 2nd contact Eligibility Assessment Treatment Follow-up
Visit Duration Week 1 Week 1 Week 1 Week 1 Week 1 Week 2–5 Week 6
10 min 10 min 1 hour 3 hours (4 × 5 × 30 min) 3 hours
Time −7d −6d −5d −4d −4-0d −2d 27d
Admission x
Medical examination x








Primary variables x x
Secondary variables x x
Concomitant therapy x
Adverse events x x
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Patients will not be restrained from CaCT or AP train-
ing if this is part of the conventional therapy of the indi-
vidual clinic. However, each trial centre is instructed to
track the types of interventions provided and provide
precise documentation of therapy treatments, medica-
tion, therapy frequency and dose.
Acupuncture treatment
For every treatment visit, participants are treated with
two acupuncture points [Baihui (GV20)] and [Shenting
(GV24)]. Patients will be treated by an experienced acu-
puncturist with a working experience of at least 2 years
in neurological rehabilitation with acupuncture. The tar-
geted acupoints are described in detail in Table 3.
Before treatments, the targeted acupoints are sterilised
with alcohol. While one hand fixates the target position,
the other hand is used to insert the needle (Huatuo, sin-
gle use, φ0.35 × 40 mm, distributor Suzhou HuaTuo
Medical Instruments, Suzhou, China). The angle of in-
sertion is approximately 10°–20° (between needle and
Table 2 Description of study interventions based on the TIDieR template*a
Item Computer-assisted cognitive training Acupuncture ACoTrain
1 Short
name
Ca CT AP ACT
2 Why Main objective is to evaluate the effects of computer-assisted cognitive training CaCT compared to AP on the outcomes of attention
assessments
Second objective is to test the effects of a combined cognitive intervention that incorporates CaCT and AP
3 What:
materials
Ca CT (RehaCom, Hasomed Inc., Germany,
http://www.hasomed.de) will be conducted
in the study. Patients will sit in front of the
RehaCom system. The training program will
be displayed on the computer screen and
they also can hear the sound feedback from
the audio system. According to different
training programs, patients will press a
special RehaCom keyboard with large
buttons to react
Acupuncture needle, which is single use,
φ 0.35 × 40 mm, will be used for acupuncture
treatment. The angle of insertion is approximately
10°–20° (between needle and scalp), the needle
should be inserted to a depth of approximately
0.3–0.5B-cun
For the combined group, patients
will receive AP and CaCT combined,
i.e. the CaCT will be performed while
the needles are inserted
4 What:
procedures
For the purpose of this study, three
submodalities of attention will be targeted
with CaCT: intensity, selectivity, and divided
attention [26]. To approach intensity of
attention, the RehaCom modules “Attention
and Concentration (AUFM)” and “Vigilance
(VIGI)” will be used. For selectivity, the
RehaCom task called “Alertness” for reaction
behaviour and reactivity will be used.
Divided attention will use the task called
“Divided Attention Training 1 and 2”. Each
task will start at the lowest difficulty level to
allow progression according to the patient’s
abilities. Only “Attention and Concentration”
and “Divided Attention Training 2” will
begin with level 4 and 2 respectively. A
detailed description of the tasks and their
content can be found on the developer’s
site (Hasomed GmbH, www.hasomed.de)
The treatment will be performed after
sterilisation of the skin on the areas where
the needles will be inserted. The patient
will be instructed to lie supine or to sit
down on a treatment chair while the doctor’s
left hand fixates the target position (DU20 and
DU24), The angle of insertion is approximately
10°–20°(between needle and scalp), the needle
should be inserted to a depth of approximately
0.3–0.5B-cun. Following insertion, a 1-minute
stimulation of the acupuncture point will be
performed using bidirectional rotation of the
needle’s sleeve. This provokes a sensation known
as Deqi, which is commonly described as a
‘glowing’ feeling. The needle will be kept in this
position for 30 minutes. The described manipulation
will be repeated every 10 minutes and the needles
will be withdrawn after the fourth manipulation
5 Who
provides
RehaCom training will be provided by
experienced neuropsychology therapists,
who will have at least 2 years of
professional experience in the field of
neurorehabilitation.
Acupuncture will be performed by acupuncturists
who have a TCM practitioner’s license, and at least
2 years of working experience
Both study interventions will
be provided by experienced
neuropsychology therapists and
acupuncture therapists, who will
have at least 2 years of professional
experience
6 How All the study interventions will be conducted individually in one-to-one sessions




During the 4-week intervention program, patients in each study group will receive the same amount of 20 sessions lasting 30 minutes
each
9 Tailoring Training and therapy content will be tailored to each patient’s preferences, and the concentration level of each patient
*Ca CT computer-assisted cognitive training, AP acupuncture, ACT AcoTrain, TCM Traditional Chinese Medicine
aItems 10, 11 and 12 of the Template for Intervention Description and Replication checklist and guide (TIDieR) template do not apply to this study
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scalp), the needle should be inserted to a depth of
approximately 0.3–0.5 cun (1 cun = 3.33 cm). Following
insertion, a 1-minute stimulation of the acupuncture
point will be performed using bidirectional rotation of
the needle’s sleeve. This provokes a sensation known
as Deqi, which is commonly described as a ‘glowing’ feel-
ing. The needle will be kept in this position for 30 minutes.
The described manipulation will be repeated every 10 mi-
nutes and the needles are withdrawn after the fourth
manipulation.
Computer-assisted cognitive training with RehaCom
It is important to note that the CaCT group will use
RehaCom (Hasomed Inc., Magdeburg, Germany, http://
www.hasomed.de) in our study. Three rehabilitation cen-
tres from different countries will be involved in our
study. Traditional cognitive training programs are deliv-
ered in individual or group format by a trained in-
structor, and differ primarily with regards to trained
abilities, length and frequency of training, and specific
strategies practiced [22]. Therefore, it is better to use a
computer-assisted training program to ensure patients
from different centres will all receive equal treatments.
RehaCom has been translated into different languages
and extensively used in cognitive rehabilitation following
the relevant diseases, for example, stroke [23], schizo-
phrenia and multiple sclerosis [24, 25].
The software has five different therapeutic programs
aimed at restoration of attention, memory, executive
functions, or visual field. Each program has one to four
different tasks to choose from for each therapy session.
For the purpose of this study, three submodalities of
attention will be targeted with CaCT: intensity, selectiv-
ity, and divided attention [26]. To approach intensity of
attention, the RehaCom task called “Attention and Con-
centration” and “Vigilance” will be used. For selectivity
the RehaCom task called “Alertness” for reaction
behaviour and reactivity will be used. Divided attention
will use the task called “Divided Attention Training 1
and 2”. Each task will start at the lowest difficulty
level to allow progression according to the patient’s
abilities. Only “Attention and Concentration” and “Di-
vided Attention Training 2” will begin with level 4
and 2 respectively. A detailed description of the tasks
and their content can be found on the developer’s site
(Hasomed GmbH, www.hasomed.de).
ACoTrain: acupuncture and computer-assisted attention
training
For the combined group, patients will receive AP and
CaCT combined, i.e. the CaCT will be performed while
the needles are inserted.
Outcome assessment
Outcomes will be measured once before intervention
(T0) and once after intervention (T1, at 4 weeks) in a 1-
to 1.5-hour assessment. Assessments will be conducted
by a trained and experienced therapist or neuropsych-
ologist blinded to group allocation. None of the asses-
sors will participate in the treatment. The study will use
a number of standardised scales to assess functional
changes. At baseline, additional assessment of basic cog-
nitive functioning will be administered for classification
of the included patients.
Primary outcome measure
Test for Attentional Performance (TAP)
The Test for Attentional Performance (TAP) is a
computer-assisted standardised neuropsychological test
[27] used to evaluate attention deficits. The procedures
included in the test battery are: Alertness and Go/No
Go for basic attention and general anticipation, in-
compatibility for divided visual-spatial attention, and
divided attention. Outcomes are measured in reaction
time (ms) and reported as percentile ranks. The TAP
test has previously been shown to be both reliable
and valid [28, 29]. Alertness is required for effective
behaviour and deemed the basis of every attention
performance. It is tested under two conditions meas-
uring reactions times.
1 (a) React to a randomly appearing cross on the screen
(click a button)
1 (b) React to a critical stimulus preceded by a cue
stimulus presented as warning tone
 Go/No-Go task tests the ability to suppress an
inappropriate reaction (control of impulsive
behaviour). This is achieved by measuring the
amount of correct reaction to the target stimuli.
Five different patterns of a square are presented,
only two are correct
Table 3 Acupuncture points selected in this protocol
Acupuncture points Location
Baihui (GV20) On the head, 5 *B-cun superior to the anterior
hairline, on the anterior median line
Note 1: GV20 is located in the depression 1
*B-cun anterior to the midpoint of the line
from the anterior hairline to the posterior
hairline
Note 2: when the ears are folded, GV20 is
located at the midpoint of the connecting
line between the auricular apices
Shenting (GV24) On the head, 0.5 *B-cun superior to the
anterior hairline, on the anterior median
line.
*B-cun: proportional bone cun. This method divides the height of the human
body into 75 equal units. Using joints on the surface of the body as the
primary landmarks, the length and width of every body part is measured by
such proportions
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 Incompatibility, a right- or left-pointing arrow
appears on the left or right side of the screen.
The patients are instructed to indicate the direction
of the arrow, not the location of the arrow
 Divided attention assesses the capacity to pay
attention to simultaneously ongoing processes.
The test presents a visual and an auditory task,
which must be processed in parallel (dual task)
Secondary outcome measures
Trail Making Test (TMT)
The TMT is a popular neuropsychological test and is in-
cluded in most cognitive test batteries [30]. The TMT
provides information on visual search, scanning, speed
of processing, mental flexibility, and executive functions.
The TMT consists of two parts. TMT-A requires an indi-
vidual to draw lines sequentially connecting 25 encircled
numbers distributed on a sheet of paper. Task require-
ments are similar for TMT-B except the person must
alternate between numbers and letters (e.g. 1, A, 2, B, 3,
C, etc.). The score on each part represents the amount of
time required to complete the task(s). The Chinese ver-
sion of the TMT-B uses Digit Symbol Coding [31]. The
reliability and validity of the TMT test has previously been
shown [32, 33].
Test des Deux Barrages (T2B)
The T2B is a commonly applied assessment in clinical
neuropsychology to test selective attention. The original
version consists of two parts, one time-independent, the
second limited to 10 minutes. For the purpose of this
study, only the latter will be applied. The test is pre-
sented on a large A3 sheet that displays two symbols in
the header line and a 40 × 25 matrix with a total of 1000
randomly assorted symbols similar to those in the
header line. Only a few of the matrix symbols are identi-
cal to the header symbols. The participant is instructed
to mark only identical ones. Test duration is 10 minutes.
After every minute, the assessor notes the progress of
the participant indicating the line and column. After
10 minutes, the amount of falsely marked symbols is
counted using a template solution. The task is to work
as quick and accurately as possible. The parameters to
quantify this are: time needed (if less than 10 minutes),
total amount of correct markings per minute, amount of
omitted symbols per minute, amount of wrong markings
per minute, sum of errors per minute (omitted or wrong
marking), percentage of errors, and range of perform-
ance (highest frequency of correct markings per minute
to lowest frequency of correct markings per minute).
National Institute of Health Stroke Scale (NIH-SS)
The NIH-SS is a standardised assessment of neurological
functions in the acute phase of stroke [34]. It is generally
used to quantify improvement of the patient’s neuro-
logical impairments on 15 items in 11 areas of different
neurological status. The administering medical doctor
observes the patient and rates each item on an ordinal
scale with three to five levels. A maximum of 42 points
can be achieved, which would correspond to severe
neurological impairment. The NIH-SS will be recorded
once to allow classification and description of the sever-
ity of stroke of the included patients. It is generally pro-
vided by the referring hospital. If not, the treating
neurologist may reconstruct it retrospectively [35].
Modified Barthel Index (MBI)
The MBI assesses impairment of daily activities in pa-
tients with neurological disorders and takes into account
available support (personal or device-specific) [36]. The
scale rates motor and cognitive functions on a five-point
Likert scale (0–4, the higher the less dependent).
EuroQol Questionnaire (EQ-5D)
The EQ-5D is a generic self-report instrument for use
as a measure of health outcome [37]. Applicable to
stroke, but also other health conditions [38], it pro-
vides a simple descriptive profile and a single index
value for health status.
Data collection methods and management
Data will be collected on digitalised Case Report Forms
(e-CRF) that will resemble the paper forms approved by
the ethics committee (p-CRF). Data will be transferred
from the output files and assessment forms to the e-CRFs
and will not be part of the patient’s case history. Forth-
with, only a participant ID will be connected to the data.
The CRF will be transferred to the data administrator of
the Data Control Centre (DCC, party A) after being
signed (digitally) by the clinical inspector. The DCC will
verify consistency, completeness, and accuracy of submit-
ted data forms. All participating trial centres will be con-
tacted by the DCC in case of uncertainties regarding the
submitted data and the DCC will inform all trial centres
on the status of the database.
All data is treated with utmost confidentiality and
made anonymous to anyone outside the study (except
the ethics committees during audit). Any further ana-
lyses will only refer to ID numbers. The key will only be
accessible to study personnel with a password for the
protected local drive where data is saved. All data and
related documents remain archived for 10 years at each
study centre before being shredded. All trial centres will
receive anonymous copies of all data in order to pro-
mote dissemination of study results.
Entering data forms and general information about
obtaining data was covered during the training session
prior to study commencement.
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Statistical methods
All allocated subjects will be analysed with the available
data, i.e. on the basis of intention-to-treat (ITT). The
last observation carried forward method will be applied
in case of missing data.
A significance level of 95 % (two sided p values
alpha <0.05) will be used. After examining the data
for normality (the Kolmogorov-Smirnov test) the outcome
measures will be analysed using ANOVA (assuming nor-
mal distribution) or Kruskal-Wallis (nonparametric test).
Demographic characteristics and other baseline values will
be described using descriptive statistics for each group.
Significant group interactions will be analysed post hoc.
The Bonferroni method will be used to appropriately
adjust the overall level of significance for multiple out-
comes. A statistician blinded to study groups will conduct
statistical analysis.
Patient safety
Adverse effects attributable to the RehaCom therapy
may include mental fatigue or headache. Symptoms usu-
ally resolve in patients as they progress with therapy and
become more familiar with it [39]. Acupuncture may
cause discomfort or bruising at the sites of needle inser-
tion, nausea, or feeling faint after each treatment.
Any medical occurrence after inclusion, which is
not necessarily caused by the intervention (adverse
events, AEs) will be recorded on the individual CRFs
and on a progress protocol. This report will be sent
to the ethics committee and the sponsor once a year
as a safety report.
Serious adverse events (SAEs) will be reported to the
sponsor immediately and all participating clinics will be
informed by the sponsor. It is the responsibility of each
study centre to inform the local ethics committee within
7 days.
Quality control
To ensure that treatments are of a high standard and de-
livered in accordance with the trial protocol, clinicians
involved in assessments, treatment or training will have
to provide a proven record of at least 3 years of clinical
experience and certified training or education in related
fields of rehabilitation or research. The acupuncture will
only be performed by professional physicians with spe-
cific training in TCM and a minimum of 2 years of ex-
perience. They will participate in a 3-day training course
in the standard operating procedures (SOPs) provided
by the author of the mutualised protocol and the stand-
ard operation videos. In this training course, the proto-
col will be explained and practiced during exercises and
role plays.
Discussion
Cognitive impairments, such as, memory, executive
function, and attention deficit frequently occur in stroke
patients, though sometimes, attentional deficit is the
only cognitive impairment apparent [40]. Sustaining at-
tention is a prerequisite of motor relearning [41], which
is essentially the mechanism of functional recovery after
stroke [42]. The traditional neurocognitive strategies
[43] used to improve attention deficit after stroke often
result in incomplete resolution, and thus, more effective
adjuvant strategies are needed.
Acupuncture focuses on the global cognitive function
from the holistic conception of TCM, while the Reha-
Com cognitive training concerns the specific impaired
cognitive functions, which need to be trained from the
viewpoint of symptomatic treatment. However, the cog-
nitive impairment after stroke is so complex that it
needs an integrated method.
The aims of our study are to compare CaCT and AP
efficacy in terms of attention improvement after stroke
and to investigate the potential effect of a combination
of both (ACT). The participants will have the study
treatment added to their existing rehabilitation program
and will be assessed for changes in attention (intensity,
selectivity, and divided attention) at 4 weeks.
Although CaCT and AP both have shown to have
beneficial effects on overall cognition in various studies,
they have not been compared directly and for specific at-
tentional performance. This is the first study of its kind
that assesses attention-specific outcomes for both
methods and not only compares the methods but also
advances into new approaches where two methods well
accepted in two very different cultures are combined to
complement one another. The multicentric approach al-
lows more generalisable interpretation [44] of the results
and the usage of standardised and cross-culturally
adapted assessments allows comparison and pooling of
all study data coming from different trial centres.
Given its small sample size, the pilot study will
mainly produce results to provide estimation of large-
scale study sample sizes and test the feasibility of the
international multicentric study design and its man-
agement. A further limitation of the study is the dis-
tinction of effects caused by the conventional training
as opposed to the experimental interventions. How-
ever, the primary aim of the study is a parallel com-
parison of three experimental interventions rather
than comparison to conventional therapy. Hence, no
control group receiving no experimental intervention
was included for methodological and ethical reasons.
This allowed the same amount of time spent with a
therapist in all intervention groups. That is deemed
as an important measure to prevent bias, particularly
when patients cannot be blinded to interventions, as
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it exposes each group to the same amount of poten-
tial placebo effects [45].
The ACoTrain study intends to assess stroke patients
of very different cultures (Asia and Europe). Great care
has been taken to select cross-culturally adapted and
validated assessments to allow pooling of the final data.
The assessments are designed to measure the same con-
struct, independent of cultural, educational, or lingual
differences. Further, patients in early stroke rehabilita-
tion often present with impairments in other areas than
cognition. When assessing cognition, however, these im-
pairments may confound the outcomes, as the task at
hand cannot be isolated from other motor and cognition
functions. Effects of motor disabilities, impaired percep-
tion (e.g. visual deficits, reduced proprioception), or
other cognitive defects (e.g. memory) and lack of motiv-
ation can limit the interpretability of attention assess-
ments [46]. The eligibility criteria were carefully selected
to exclude such confounding factors. To further pro-
mote internal validity of the assessments, trained and ex-
perienced neuropsychologists will educate all assessors
accordingly. To achieve this, a series of assessment train-
ing workshops for all personnel involved in the study
have been held twice prior to the beginning of the study





ACoTrain: ACT, intervention that incorporates CCT and AP; AEs: Adverse
events; AP: Acupuncture; BL: Baseline; Ca CT: Computer-assisted cognitive
training; DCC: Data Control Centre; e-CRF: Digitalised Case Report Form;
EQ-5D: EuroQol Questionnaire; ITT: Intention-to-treat; KAP: Short aphasia test;
MBI: Modified Barthel Index; MoCA: Montreal Cognitive Assessment;
NIH-SS: National Institute of Health Stroke Scale; p-CRF: Paper Case Report
Form; RCTs: Randomised controlled trials; SAEs: Serious adverse events;
SOPs: Standard operating procedures; T2B: Test des Deux Barrages; TAP:
Test for Attentional Performance; TCM: Traditional Chinese Medicine;
TIDieR: Template for Intervention Description and Replication checklist and
guide; TMT: Trail Making Test.
Competing interests
All participating parties declare no conflict of interest, whether intellectual,
financially, or proprietary. The authors declare that they have no competing,
financial, or commercial interests.
Authors’ contributions
CS, WS, TE, HK, CB, YS, LC, and JT contributed to conception and design,
critical revision for important intellectual content and final approval of the
manuscript. MM, HJ, and HY contributed to conception and design, drafting
the manuscript and final approval of the manuscript. MM, HJ, HK, CB, LC, HY,
CJ and SY contributed to the final approval of the manuscript. All authors
have read and approved the manuscript.
Acknowledgements
It is supported by the Rehabilitation Research Center of Fujian Province and
the Rehabilitation Research Center for Traditional Chinese Medicine, State
Administration of Traditional Chinese Medicine of the People's Republic of
China. The Collaborative Innovation Center for Rehabilitation Technology.
Funding
This study is funded by the International Science and Technology
Cooperation Program (No. 2011DFG33240); the Ministry of Science and
Technology of the People’s Republic of China; the National Natural Science
Foundation of China (No. 81403462); and university-supported funding
from Fujian University of Traditional Chinese Medicine (Type A Science and
Technology, X2013006). It is supported by the Fujian Key Laboratory of
Rehabilitation Technology.
Author details
1College of Rehabilitation Medicine, Fujian University of Traditional Chinese
Medicine, No.1 Huatuo Road, Minhou District, Fuzhou 350122, Fujian
Province, China. 2Fujian University of Traditional Chinese Medicine Affiliated
Rehabilitation Hospital, No. 282 Wusi Road, Fuzhou 350003, Fujian Province,
China. 3Research Department, Reha Rheinfelden, Salinenstrasse 98, 4310
Rheinfelden, Switzerland. 4m&i-Fachklinik Herzogenaurach, In der Reuth 1,
91074 Herzogenaurach, Germany.
Received: 7 May 2015 Accepted: 12 November 2015
References
1. Zhu L, Fratiglioni L, Guo Z, Aguero-Torres H, Winblad B, Viitanen M,
et al. Association of stroke with dementia, cognitive impairment, and
functional disability in the very old: a population-based study. Stroke.
1998;29:2094–9.
2. Hochstenbach JB, Anderson PG, van Limbeek J, Mulder TT. Is there a
relation between neuropsychologic variables and quality of life after stroke?
Arch Phys Med Rehabil. 2001;82:1360–6.
3. Hyndman D, Pickering RM, Ashburn A. The influence of attention deficits on
functional recovery post stroke during the first 12 months after discharge
from hospital. J Neurol Neurosurg Psychiatry. 2008;79:656–63.
4. Jokinen H, Kalska H, Mantyla R, Pohjasvaara T, Ylikoski R, Hietanen M, et al.
Cognitive profile of subcortical ischaemic vascular disease. J Neurol
Neurosurg Psychiatry. 2006;77:28–33.
5. Lindeboom J, Weinstein H. Neuropsychology of cognitive ageing, minimal
cognitive impairment, Alzheimer's disease, and vascular cognitive
impairment. Eur J Pharmacol. 2004;490:83–6.
6. Sachdev PS, Brodaty H, Valenzuela MJ, Lorentz L, Looi JC, Wen W, et al.
The neuropsychological profile of vascular cognitive impairment in stroke
and TIA patients. Neurology. 2004;62:912–9.
7. Nyenhuis DL, Gorelick PB, Geenen EJ, Smith CA, Gencheva E, Freels S, et al.
The pattern of neuropsychological deficits in Vascular Cognitive
Impairment-No Dementia (Vascular CIND). Clin Neuropsychol. 2004;18:41–9.
8. Styles E. The psychology of attention. Hove: Psychology Press; 2006.
9. Hugdahl K, Thomsen T, Ersland L, Rimol LM, Niemi J. The effects of
attention on speech perception: an fMRI study. Brain Lang. 2003;85:37–48.
10. Posner MI, Cohen Y, Rafal RD. Neural systems control of spatial orienting.
Philos Trans R Soc Lond B Biol Sci. 1982;298:187–98.
11. Gouze KR. Attention and social problem solving as correlates of aggression
in preschool males. J Abnorm Child Psychol. 1987;15:181–97.
12. Petersen SE, Posner MI. The attention system of the human brain: 20 years
after. Annu Rev Neurosci. 2012;35:73–89.
13. Wulf G, editor. Attention and motor skill learning. Champaign: Human
Kinetics; 2007.
14. Loetscher T, Lincoln NB. Cognitive rehabilitation for attention deficits
following stroke. Cochrane Database Syst Rev. 2013;5, CD002842.
15. Chu YT, Bi Z. An ancient literature review of acupuncture for apoplexy
[in Chinese]. Shanghai Acupunct Moxibustion. 1998;17:42–3.
16. Liu F, Li ZM, Jiang YJ, Chen LD. A meta-analysis of acupuncture use in the
treatment of cognitive impairment after stroke. J Altern Complement Med.
2014;20:535–44.
17. Chuang CM, Hsieh CL, Li TC, Lin JG. Acupuncture stimulation at Baihui
acupoint reduced cerebral infarct and increased dopamine levels in chronic
cerebral hypoperfusion and ischemia-reperfusion injured Sprague–Dawley
rats. Am J Chin Med. 2007;35:779–91.
18. Feng X, Yang S, Liu J, Huang J, Peng J, Lin J, et al. Electroacupuncture
ameliorates cognitive impairment through inhibition of NF-kappaB-
mediated neuronal cell apoptosis in cerebral ischemia-reperfusion injured
rats. Mol Med Rep. 2013;7:1516–22.
Huang et al. Trials  (2015) 16:546 Page 9 of 10
19. Lin Y, Tao J, Chen B, Yang S, Huang J, Chen L, et al. Effect of
electroacupuncture on learning and memory ability of cerebral ischemia/
reperfusion injured rats. Chinese J Rehab Theory Prac. 2014;9:11.
20. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I,
et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for
mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
21. Altman DG, Bland JM. How to randomise. BMJ. 1999;319:703–4.
22. Kueider AM, Parisi JM, Gross AL, Rebok GW. Computerized cognitive training
with older adults: a systematic review. PLoS One. 2012;7:e40588.
23. Yoo C, Yong M H, Chung J. Effect of computerized cognitive rehabilitation
program on cognitive function and activities of living in stroke patients [J].
Journal of Physical Therapy Science. 2015;27(8):2487–2489.
24. Bor J, Brunelin J, D'Amato T, Costes N, Suaud-Chagny MF, Saoud M, et al.
How can cognitive remediation therapy modulate brain activations in
schizophrenia? An fMRI study. Psychiatry Res. 2011;192:160–6.
25. Solari A, Motta A, Mendozzi L, Pucci E, Forni M, Mancardi G, et al.
Computer-aided retraining of memory and attention in people with
multiple sclerosis: a randomized, double-blind controlled trial. J Neurol Sci.
2004;222:99–104.
26. Schuhfried G. RehaCom: basic manual. Version 5. Magdeburg: Hasomed;
2003. Available from: https://www.hasomed.de/de/rehacom/
therapiemodule.html. 2013.
27. Zimmerman P, Fimm B. Test battery of attentional performance (TAP)
(version 2.3. 2012). Available from: http://www.psytest.net.
28. Bühner M, Ziegler M, Bohnes B, Lauterbach K. Übungseffekte in den TAP
untertests test Go/nogo und geteilte aufmerksamkeit sowie dem
aufmerksamkeits-belastungstest. Z Neuropsychol. 2008;17:191–99.
29. Beck L, Heusinger A, Böcker M, Niemann H, Gauggel S. Convergent and
predictive validity of two computerized attention tests in brain-damaged
patients. Z Neuropsychol. 2008;19:213–22.
30. Tombaugh TN. Trail Making Test A and B: normative data stratified by age
and education. Arch Clin Neuropsychol. 2004;19:203–14.
31. Lu L, Bigler ED. Performance on original and a Chinese version of Trail
Making Test Part B: a normative bilingual sample. Appl Neuropsychol. 2000;
7:243–6.
32. Giovagnoli AR, Del PM, Mascheroni S, Simoncelli M, Laiacona M, Capitani E.
Trail making test: normative values from 287 normal adult controls. Ital J
Neurol Sci. 1996;17:305–9.
33. Sanchez-Cubillo I, Perianez JA, Adrover-Roig D, Rodriguez-Sanchez JM,
Rios-Lago M, Tirapu J, et al. Construct validity of the Trail Making Test: role
of task-switching, working memory, inhibition/interference control, and
visuomotor abilities. J Int Neuropsychol Soc. 2009;15:438–50.
34. Fischer U, Arnold M, Nedeltchev K, Brekenfeld C, Ballinari P, Remonda L,
et al. NIHSS score and arteriographic findings in acute ischemic stroke.
Stroke. 2005;36:2121–5.
35. Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave
JN, et al. Effect of urgent treatment of transient ischaemic attack and minor
stroke on early recurrent stroke (EXPRESS study): a prospective population-
based sequential comparison. Lancet. 2007;370:1432–42.
36. Jansa J, Pogacnik T, Gompertz P. An evaluation of the Extended Barthel
Index with acute ischemic stroke patients. Neurorehabil Neural Repair.
2004;18:37–41.
37. Rabin R, Gudex C, Selai C, Herdman M. From translation to version
management: a history and review of methods for the cultural adaptation
of the EuroQol five-dimensional questionnaire. Value Health. 2014;17:70–6.
38. Janssen MF, Lubetkin EI, Sekhobo JP, Pickard AS. The use of the EQ-5D
preference-based health status measure in adults with Type 2 diabetes
mellitus. Diabet Med. 2011;28:395–413.
39. Fernandez E, Bringas ML, Salazar S, Rodriguez D, Garcia ME, Torres M, et al.
Clinical impact of RehaCom software for cognitive rehabilitation of patients
with acquired brain injury. Medicc Rev. 2012;14:32–5.
40. Tatemichi TK, Desmond DW, Stern Y. Cognitive impairment after stroke:
frequency, patterns, and relationship to functional abilities. J Neurol
Neurosurg Psychiatry. 1994;57:202–7.
41. McNevin NH, Wulf G, Carlson C. Effects of attentional focus, self-control, and
dyad training on motor learning: implications for physical rehabilitation.
Phys Ther. 2000;80:373–85.
42. Hikosaka O, Nakamura K, Sakai K. Central mechanisms of motor skill
learning. Curr Opin Neurobiol. 2002;12:217–22.
43. Coulthard E, Singh-Curry V, Husain M. Treatment of attention deficits in
neurological disorders. Curr Opin Neurol. 2006;19:613–8.
44. Localio AR, Berlin JA, Ten HT, Kimmel SE. Adjustments for center in
multicenter studies: an overview. Ann Intern Med. 2001;135:112–23.
45. Birch S. A review and analysis of placebo treatments, placebo effects, and
placebo controls in trials of medical procedures when sham is not inert.
J Altern Complement Med. 2006;12:303–10.
46. Sangha H, Lipson D, Foley N, Salter K, Bhogal S, Pohani G, et al. A comparison
of the Barthel Index and the Functional Independence Measure as outcome
measures in stroke rehabilitation: patterns of disability scale usage in clinical
trials. Int J Rehabil Res. 2005;28:135–9.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Huang et al. Trials  (2015) 16:546 Page 10 of 10
